Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Carbogen Amcis CEO to Step Down in March | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Carbogen Amcis CEO to Step Down in March

Stephan Fritschi to succeed Pascal Villemagne.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Stephan Fritschi.

Switzerland-based Carbogen Amcis, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has announced the departure of its current CEO, Pascal Villemagne, and the appointment of his replacement, Stephan Fritschi.

After thirteen years with Carbogen Amcis, the last three of which he served as Chief Executive Officer (CEO), Pascal Villemagne has announced his intent to step down. He will remain in his role until March 31, 2025, and facilitate the handover to the new CEO.

Stephan Fritschi, currently serving as Chief Alliance Officer and deputy CEO, will assume the role of CEO, effective April 1, 2025.

“With more than 25 years at Carbogen Amcis, a perfect knowledge of the company and extensive experience in the pharmaceutical market, Stephan Fritschi brings a deep understanding of the company’s operations, values, and strategic direction, he assures continuity in growing the business,” stated Christian Eich, Chairman of Carbogen Amcis.

“I am honored to take on this role and lead Carbogen Amcis into the future. I look forward to collaborating with the team to continue the progress we have made and to build on the foundations laid by my predecessor, ensuring we continue to deliver value to our customers, employees, and stakeholders,” Stephan Fritschi remarked.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics